{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "42"
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Autosomal recessive juvenile Parkinson’s disease (ARJP) is an early onset familial form of Parkinson’s disease (PD) that is clinically indistinguishable from the more prevalent idiopathic form of PD. Mutations in ARJP patients have been identified in several genes, although the most commonly mutated gene encodes an E3 ubiquitin-protein ligase termed parkin.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as mutations in the E3 ubiquitin-protein ligase parkin, which is involved in the ubiquitination pathway responsible for protein degradation and other cellular processes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study examines the folding and structure of the parkin ubiquitin-like domain (Ubld) and of the protein with two causative disease mutations (K48A and R42P) using urea unfolding experiments, NMR spectroscopy, and size exclusion chromatography.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis by assessing the effects of mutations on protein structure and stability, which are central to the function of parkin in the ubiquitination pathway.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper provides a detailed description of the methods used for cloning, protein expression and purification, and unfolding experiments, which are standard techniques in the field. The use of wild-type and mutant proteins, as well as the comparison with ubiquitin, strengthens the validity of the assays."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4c: Correlate OddsPath",
          "extracted_paper_info": "The R42P mutation in parkin’s Ubld caused poor expression and degradation of the protein, and the GB1-Ubld fusion protein characterized by NMR spectroscopy showed that the R42P mutation causes the complete unfolding of the parkin Ubld.",
          "judgment": "Yes",
          "reasoning": "The functional data clearly demonstrate that the R42P mutation leads to a drastic alteration in the structure and stability of the parkin Ubld, resulting in dysfunction of the protein in the ubiquitination pathway.",
          "next_step_or_outcome": "PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The R42P mutation in the parkin Ubld was shown to cause complete unfolding of the domain and significantly decrease its stability, leading to dysfunction in the ubiquitination pathway. This provides strong evidence for the pathogenicity of the R42P variant in autosomal recessive juvenile Parkinson’s disease."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "A",
          "position": "48"
        },
        "variant_string_id": "PARK2 K48A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Autosomal recessive juvenile Parkinson’s disease (ARJP) is an early onset familial form of Parkinson’s disease (PD) that is clinically indistinguishable from the more prevalent idiopathic form of PD. Mutations in ARJP patients have been identified in several genes, although the most commonly mutated gene encodes an E3 ubiquitin-protein ligase termed parkin.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as mutations in the E3 ubiquitin-protein ligase parkin, which is involved in the ubiquitination pathway responsible for protein degradation and other cellular processes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study examines the folding and structure of the parkin ubiquitin-like domain (Ubld) and of the protein with two causative disease mutations (K48A and R42P) using urea unfolding experiments, NMR spectroscopy, and size exclusion chromatography.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis by assessing the effects of mutations on protein structure and stability, which are central to the function of parkin in the ubiquitination pathway.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper provides a detailed description of the methods used for cloning, protein expression and purification, and unfolding experiments, which are standard techniques in the field. The use of wild-type and mutant proteins, as well as the comparison with ubiquitin, strengthens the validity of the assays."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_name": "4b: No OddsPath Calculation",
          "extracted_paper_info": "The K48A mutation had little effect on the stability of the parkin Ubld or ubiquitin, indicating that this mutation contributes to defective protein-protein interactions.",
          "judgment": "Yes",
          "reasoning": "The functional data show that the K48A mutation does not significantly affect the stability of the parkin Ubld, but rather impacts protein-protein interactions, which is consistent with its role in disease.",
          "next_step_or_outcome": "PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The K48A mutation in the parkin Ubld was shown to have little effect on protein stability but likely leads to modified interactions with the proteasome, providing supporting evidence for the pathogenicity of the K48A variant in autosomal recessive juvenile Parkinson’s disease."
    }
  ]
}